Form 8-K - Current report:
SEC Accession No. 0001213900-19-007317
Filing Date
2019-04-29
Accepted
2019-04-29 17:12:27
Documents
4
Period of Report
2019-04-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k042319_wizepharmainc.htm 8-K 34555
2 CHAIRMAN AGREEMENT BETWEEN THE COMPANY AND MARK SIECZKAREK DATED AS OF APRIL 23, f8k042319ex10-1_wizepharma.htm EX-10.1 44615
3 PRESS RELEASE DATED AS OF APRIL 23, 2019 f8k042319ex99-1_wizepharma.htm EX-99.1 11094
4 GRAPHIC ex99-1_001.jpg GRAPHIC 24830
  Complete submission text file 0001213900-19-007317.txt   126088
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 19777046
SIC: 2834 Pharmaceutical Preparations